Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma.

Future oncology (London, England) - 1 Jul 2017

Dong Yan, Cai Ying, Liu Bo, Jiao Xiang, Li Zhong-Tai, Guo Da-Yong, Li Xin-Wei, Wang Yong-Jun, Yang Deng-Ke

Abstract excerpt

AIM: To investigate the clinical relevance and functional role of HOXA13 in prostate cancer Methods: PCR, western blot and immunohistochemistry were performed to determine the expression. Kaplan-Meier and Cox regression survival analyses investigated the clinical relevance. Cell viability, flow cytometry and transwell assays were used to determine the functional roles. RESULTS: HOXA13 expression is sharply...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Carcinoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Gene Expression Regulation, Neoplastic

Share to Homeodomain Proteins

Share to Kaplan-Meier Estimate

Share to Oncogenes

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 28766961
DOI: 10.2217/fon-2016-0522

Genes

HOXA13

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma.PMID 28766961Read ↗

Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathwaySemantic proximity Read ↗

Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS/STING/IRF3 pathwaySemantic proximity Read ↗

HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expressionSemantic proximity Read ↗

Neuroendocrine prostate cancer has distinctive, non-prostatic HOX code that is represented by the loss of HOXB13 expressionSemantic proximity Read ↗

HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directionsSemantic proximity Read ↗

Association of Homeobox B13 (HOXB13) Gene Variants with Prostate Cancer Risk in Iranian PopulationSemantic proximity Read ↗

HOXD13 suppresses prostate cancer metastasis and BMP4 ‐induced epithelial‐mesenchymal transition by inhibiting SMAD1Semantic proximity Read ↗

The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate CancersSemantic proximity Read ↗

HOXB13 and other high penetrant genes for prostate cancer.Semantic proximity Read ↗

Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.Semantic proximity Read ↗

Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer.Semantic proximity Read ↗

PBX3 is a putative biomarker of aggressive prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.